Literature DB >> 16574856

Immunology. An antibody paradox, resolved.

Martin Prlic1, Michael J Bevan.   

Abstract

Mesh:

Substances:

Year:  2006        PMID: 16574856     DOI: 10.1126/science.1126030

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  5 in total

1.  Incorporation of CD40 ligand into SHIV virus-like particles (VLP) enhances SHIV-VLP-induced dendritic cell activation and boosts immune responses against HIV.

Authors:  Rongxin Zhang; Sheng Zhang; Min Li; Changyi Chen; Qizhi Yao
Journal:  Vaccine       Date:  2010-05-14       Impact factor: 3.641

2.  Interleukin-2/interleukin-2 antibody therapy induces target organ natural killer cells that inhibit central nervous system inflammation.

Authors:  Junwei Hao; Denise Campagnolo; Ruolan Liu; Wenhua Piao; Samuel Shi; Baoyang Hu; Rong Xiang; Qinghua Zhou; Timothy Vollmer; Luc Van Kaer; Antonio La Cava; Fu-Dong Shi
Journal:  Ann Neurol       Date:  2011-03-18       Impact factor: 10.422

3.  IL-2 complex treatment amplifies CD8+ T cell mediated immunity following herpes simplex virus-1 infection.

Authors:  Naveen K Rajasagi; Barry T Rouse
Journal:  Microbes Infect       Date:  2016-11-17       Impact factor: 2.700

4.  Rapid generation of a functional NK-cell compartment.

Authors:  Martin Prlic; Daisuke Kamimura; Michael J Bevan
Journal:  Blood       Date:  2007-06-06       Impact factor: 22.113

5.  CIMT 2013: advancing targeted therapies--report on the 11th Annual Meeting of the Association for Cancer Immunotherapy, May 14-16 2013, Mainz, Germany.

Authors:  Mustafa Diken; Sebastian Attig; Christian Grunwitz; Lena Kranz; Petra Simon; Niels van de Roemer; Fulvia Vascotto; Sebastian Kreiter
Journal:  Hum Vaccin Immunother       Date:  2013-07-22       Impact factor: 3.452

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.